Blockchain Registration Transaction Record

Lexaria Bioscience Announces Interim Results from Diabetes Animal Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW) announces interim results from diabetes animal study, revealing significant findings related to weight reduction and potential implications for diabetes treatment.

Lexaria Bioscience Announces Interim Results from Diabetes Animal Study

This news matters as it highlights the potential of Lexaria's DehydraTECH-processed drug therapy in reducing body weight gain in diabetes animal study, which could have significant implications for the treatment of diabetes and related conditions.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x54c955b1c90c816ce75f36bb873c0d4e4cc4661e1d21e5517d14b84aba38fe91
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintmoonQKfQ-20186a4741dcc77790032a252ac1e4af